Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune-evasion. Surface is based in Cambridge, Mass.
Type
Private
HQ
Cambridge, US
Founded
2014
Employees
26 (est)+9%
Surface Oncology was founded in 2014 and is headquartered in Cambridge, US

Surface Oncology Locations

Cambridge, US

Surface Oncology Metrics

Surface Oncology Summary

Founding Date

2014

Total Funding

$35 M

Latest funding size

$35 M

Time since last funding

almost 2 years

Investors

Surface Oncology's latest funding round of $35 M was in January 2015. In total, Surface Oncology has raised $35 M.
40% of current employees of Surface Oncology are female and 60% are male.

Surface Oncology News

Surface Oncology Company Life

You may also be interested in